Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Change in Account Payables: 2020-2024

Historic Change in Account Payables for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to -$5.3 million.

  • Prime Medicine's Change in Account Payables rose 100.79% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 174.24%. This contributed to the annual value of -$5.3 million for FY2024, which is 157.52% down from last year.
  • According to the latest figures from FY2024, Prime Medicine's Change in Account Payables is -$5.3 million, which was down 157.52% from $9.1 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Change in Account Payables ranged from a high of $9.1 million in FY2023 and a low of -$5.3 million during FY2024.
  • Over the past 3 years, Prime Medicine's median Change in Account Payables value was $2.5 million (recorded in 2022), while the average stood at $2.1 million.
  • Per our database at Business Quant, Prime Medicine's Change in Account Payables soared by 374.00% in 2021 and then plummeted by 157.52% in 2024.
  • Prime Medicine's Change in Account Payables (Yearly) stood at $250,000 in 2020, then surged by 374.00% to $1.2 million in 2021, then spiked by 107.43% to $2.5 million in 2022, then soared by 271.85% to $9.1 million in 2023, then crashed by 157.52% to -$5.3 million in 2024.